| Aug 28 |
Is Johnson & Johnson (JNJ) The Best Dividend Paying Stock To Buy According to Quant Hedge Fund AQR?
|
| Aug 28 |
J&J's Rybrevant Receives EU Approval for Expanded Use in NSCLC
|
| Aug 28 |
LifeNet launches newest bone allograft gel with Johnson & Johnson
|
| Aug 28 |
Johnson & Johnson (JNJ): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
| Aug 27 |
EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC
|
| Aug 27 |
Merck Stock Worth Watching on PAH Drug Winrevair's Approval in Europe?
|
| Aug 27 |
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
|
| Aug 27 |
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
|
| Aug 27 |
Biosense Webster completes enrolment for Omnypulse Platform trial
|
| Aug 27 |
Johnson & Johnson is transforming solid tumor cancer outcomes with new data at the 2024 World Conference on Lung Cancer and European Society for Medical Oncology Congress
|
